Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-10-13

Clinical Trial Update: Inhalation/Nasal Corticosteroids and Prevalence of Hypothalamic-pituitary-adrenal (HPA) Axis Suppression in Human Immunodeficiency Virus (HIV)-Patients [NA]

View source ↗

Summary

A clinical trial update reports on the prevalence of hypothalamic-pituitary-adrenal axis suppression from inhaled or intranasal corticosteroids in HIV-infected …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inhaled and intranasal corticosteroids

Snippet

Sponsor: Radboud University Medical Center | Conditions: Adrenal Insufficiency | NA | Status: UNKNOWN